Open Orphan plc changes its name to hVIVO plc, learn more here.

Media Press Kit

We at hVIVO (formerly Open Orphan) are a rapidly growing specialist contract research organisation (CRO) and the world leader in testing infectious and respiratory disease vaccines and therapeutics using human challenge clinical trials.

Explore valuable resources below, featuring the most recent hVIVO plc investor presentation, officially approved company descriptions, and captivating images suitable for editorial use, provided the association with hVIVO, Venn Life Sciences, and FluCamp is prominently identifiable. Please note that commercial usage is strictly prohibited. 

Open Orphan logo on March 2022 presentation

Download Latest Presentation

30 Jan 2024
Trading Update H1 2023
Download

Images - hVIVO

Download icon
Cathal Friel – Chairman hVIVO plc
(152 KB - JPG)
Download icon
Yamin Khan – Chief Executive Officer hVIVO plc
(195 KB - JPG)
Download icon
Stephen Pinkerton – Chief Financial Officer hVIVO plc
(640 KB - JPG)
Download icon
Dr Andrew Catchpole – Chief Scientific Officer hVIVO plc
(196 KB - JPG)
Download icon
Adam French – VP of Clinical Operations
(135 KB - JPG)
Download icon
Mariya Kalinova – Medical Director
(94 KB - JPG)
Download icon
hVIVO Inoculation 1
(543 KB - JPG)
Download icon
hVIVO Inoculation 2
(555 KB - JPG)
Download icon
hVIVO Inoculation 3
(608 KB - JPG)
Download icon
hVIVO Inoculation 4
(338 KB - JPG)
Download icon
FluCamp Nurse 1
(16.7 MB - JPG)
Download icon
hVIVO FluCamp 1
(107 KB - JPG)
Download icon
hVIVO FluCamp 2
(3 MB - JPG)
Download icon
hVIVO FluCamp 3
(3 MB - JPG)
Download icon
hVIVO FluCamp 4
(2 MB - JPG)
Download icon
hVIVO FluCamp 5
(2 MB - JPG)
Download icon
FluCamp Volunteer 1
(22 MB - JPG)
Download icon
Whitechapel Clinic Quarantine Room 1
(3 MB - JPG)
Download icon
hVIVO Lab 1
(20.9 MB - JPG)
Download icon
hVIVO Lab 2
(3 MB - JPG)
Download icon
hVIVO Lab 3
(18 MB - JPG)

hVIVO Description

hVIVO plc (ticker: HVO) (formerly Open Orphan plc) is a rapidly growing specialist contract research organisation (CRO) and the world leader in testing infectious and respiratory disease vaccines and therapeutics using human challenge clinical trials. The Group provides end-to-end early clinical development services to its large, established and growing repeat client base, which includes four of the top 10 largest global biopharma companies.

The Group's fast-growing services business includes a unique portfolio of 11 human challenge models, with a number of new models under development, to test a broad range of infectious and respiratory disease products. The Company has world class challenge agent manufacturing, specialist drug development and clinical consultancy services via its Venn Life Sciences brand, and a lab offering via its hLAB brand, which includes virology, immunology biomarker and molecular testing. The Group offers additional clinical field trial services such as patient recruitment and clinical trial site services.

hVIVO runs challenge studies in London from its Whitechapel quarantine clinic, its state-of-the-art QMB clinic with its highly specialised on-site virology and immunology laboratory, and its clinic in Plumbers Row. To recruit volunteers / patients for its studies, the Company leverages its unique clinical trial recruitment capability via its FluCamp volunteer screening facilities in London and Manchester.

If you’re a potential customer, job seeker, health professional or an investor, find out how we can help you.

Contact hVIVO
chevron-down